click below
click below
Normal Size Small Size show me how
Renal/Hepatic
Hepatitis & Liver Disease
| Term | Definition |
|---|---|
| Comparison of Hepatitis Viruses | A: acute, via fecal-oral route, has vaccine, supportive tx only B: acute & chronic, via blood/body fluids, has vaccine, 1st line tx is PEG-IFN or NRTI (tenofovir or entacavir) C: acute and chronic, via blood, no vaccine, DAA combo or DAA combo + RBV |
| Comparison of Hepatitis Viruses | A: acute, via fecal-oral route, has vaccine, supportive tx only B: acute & chronic, via blood/body fluids, has vaccine, 1st line tx is PEG-IFN or NRTI (tenofovir or entacavir) C: acute and chronic, via blood, no vaccine, DAA combo or DAA combo + RBV |
| DAA Mechanisms and Regimens | NS3/4A Protease inhibitors: end in -previr; "P for PI"; (glecaprevir) NS5A Replication Complex Inhibtors; end in -asvir; "A for NS5A";(pibrentasvir, velpatasvir) NS5B Polymerase Inhibitors: end in -buvir; "B for NS5B"; (sofosbuvir) |
| DAA Mechanisms and Regimens | NS3/4A Protease inhibitors: end in -previr; "P for PI"; (glecaprevir) NS5A Replication Complex Inhibtors; end in -asvir; "A for NS5A";(pibrentasvir, velpatasvir) NS5B Polymerase Inhibitors: end in -buvir; "B for NS5B"; (sofosbuvir) |
| Recommended regimens for treatment-naive | Glecaprevir/pibrentasvir (Mavyret) x 8 weeks Sofosbuvir/velpatasvir (Epclusa) x 12 weeks **BBW for HBV reactivation. Test all pts before initiation** |
| Recommended regimens for treatment-naive | Glecaprevir/pibrentasvir (Mavyret) x 8 weeks Sofosbuvir/velpatasvir (Epclusa) x 12 weeks **BBW for HBV reactivation. Test all pts before initiation** |
| Mavyret counseling points | Do not use with select statins (atorvastatin, lovastatin, simvastatin) Take with food |
| Mavyret counseling points | Do not use with select statins (atorvastatin, lovastatin, simvastatin) Take with food |
| Epclusa counseling points | Do not use with amiodarone for risk of bradycardia Antacids (separate by 4 hours), H2RAs(take at same time or separate by 12 hours), & PPIs (not recommended) can decrease concentrations Dispense in original container |
| Ribavirin | Can be used in combination with DAA, but never monotherapy. BBWs for teratogenicity and hemolytic anemia |
| Drug Treatment for Hepatitis B | TDF (Viread)- preferred; renal & bone tox > TAF TAF (Vemlidy) - preferred Entecavir (Baraclude) - preferred; take on empty stomach Lamivudine (Epivir) **BBWs for lactic acidosis & hepatomegaly w/ steatosis** |
| Interferon Alfa | Pegylated form is approved as HBV monotherapy Has multiple toxicities (BBW for neuropsychiatric, autoimmune, ischemic, or infectious disorders) AE = |
| Ribavirin | Can be used in combination with DAA, but never monotherapy. BBWs for teratogenicity and hemolytic anemia |
| Drug Treatment for Hepatitis B | TDF (Viread)- preferred; renal & bone tox > TAF TAF (Vemlidy) - preferred Entecavir (Baraclude) - preferred; take on empty stomach Lamivudine (Epivir) **BBWs for lactic acidosis & hepatomegaly w/ steatosis** |
| Interferon Alfa | Pegylated form is approved as HBV monotherapy Has multiple toxicities (BBW for neuropsychiatric, autoimmune, ischemic, or infectious disorders) AE = Myelosuppression, CNS effects, GI upset, LFT increase, flu-like symptoms |
| Most common causes of cirrhosis | Hepatitis C and alcohol consumption |
| Clinical presentation of cirrhosis | Yellowed skin and whites of the eyes (jaundice), darkened urine, light-colored stools |
| Objective Criteria for cirrhosis | Increased ALT, AST, alkaline phosphatase, total bilirubin, LDH, PT, and INR. Decreased albumin |
| Key Drugs with BBW for Liver Damage | Acetaminophen Amiodarone Isoniazid Ketoconazole MTX Nefazodone Nevirapine Propylthiouracil Valproic Acid Zidovudine |
| Treatment for Alcohol-associated liver disease | 1. alcohol cessation 2. BZDs can control withdrawal 3. naltrexone, acamprosate, and disulfiram can prevent relapse 4. thiamine can prevent and treat Wernicke-Korsakoff syndrome |
| Complications of Liver Disease & Cirrhosis | Portal HTN & Variceal bleeding: Octreotide, vasopressin, band ligation for Tx. Nadolol, propranolol, carvedilol for prevention. CTX or cipro to reduce infection risk HE: Lactulose, rifaximin can lower the amount of ammonia, also limit animal protein |
| Ascites | Fluid accumulation within the peritoneal space. Restrict sodium intake to < 2g/day Diuretic therapy is spironolactone +/- furosemide at a 100:40 mg ratio Paracentesis can remove fluid and should be supplemented with albumin if > 5L removed |
| Spontaneous bacterial peritonitis | Acute infection of the ascitic fluid Target streptococci and enteric gram negative CTX or an equivalent for 5-7 days Survivors should receive secondary prophylaxis with oral cipro or bactrim |